ADHD and Gut Health

ADHD and Gut Health: Understanding the Microbiome-Gut-Brain Connection

Attention-deficit/hyperactivity disorder (ADHD) affects millions of children and adults worldwide, creating significant challenges in daily functioning, academic performance, and social relationships. While traditionally viewed as a purely neurological condition, emerging research is revealing fascinating connections between ADHD and the gut microbiome—the trillions of microorganisms residing in our digestive system. This groundbreaking perspective is opening new avenues for understanding ADHD and gut health, and potentially treating ADHD through the lens of the microbiome-gut-brain axis.

What is ADHD?

ADHD is the most common neurodevelopmental disorder in children and adolescents, affecting approximately 5% of individuals younger than 18 years. The condition is characterised by persistent patterns of inattention and/or hyperactivity-impulsivity that interfere with functioning or development. These core symptoms must appear before the age of 12 according to current diagnostic criteria (DSM-5).

The disorder manifests differently across individuals, but common symptoms include:

• Inattention: Difficulty sustaining focus, easily distracted, trouble organising tasks, forgetfulness in daily activities
• Hyperactivity: Excessive fidgeting, inability to remain seated, restlessness, talking excessively
• Impulsivity: Interrupting others, difficulty waiting turns, making hasty decisions without considering consequences

The course of ADHD is variable, with symptoms persisting into adulthood in approximately 40–60% of cases. The condition significantly impacts multiple aspects of life, including physical health, academic achievement, occupational functioning, and social relationships. ADHD frequently co-occurs with other conditions such as autism spectrum disorder, mood disorders, epilepsy, and sleep problems.

The Pathophysiology of ADHD

The underlying mechanisms of ADHD are complex and multifactorial. Genetic factors represent around 70–80% of the aetiology, but environmental factors also play crucial roles, including perinatal complications, psychosocial determinants, and early-life exposures.

ADHD has been associated with dysregulation of catecholaminergic neurotransmission, particularly involving dopamine and norepinephrine systems. These neurotransmitter imbalances affect executive functions such as behavioural inhibition, working memory, planning, and organisation, which are primarily mediated by neural networks involving the prefrontal cortex and dopaminergic mesolimbic system.

Recent evidence suggests that neuroinflammation and oxidative stress may perpetuate the neurochemical alterations responsible for ADHD, with increased levels of oxidative stress markers and decreased concentrations of antioxidants found in affected individuals. Additionally, alterations in mitochondrial function in dopaminergic neurons have been reported, leading to uncontrolled production of reactive oxygen species that can damage neuronal membranes and trigger inflammatory cascades.

Discover the reasons for your gut symptoms.

View our gut health tests

The Gut-Brain Axis: A Bidirectional Communication Network

To understand how gut health relates to ADHD, we must first appreciate the remarkable communication system linking our digestive system with our brain. The bidirectional connection between the gut microbiome and the central nervous system (CNS), known as the microbiota–gut–brain axis (MGBA), is mediated by immune, neuroendocrine, and neuronal pathways.

The Three Pathways of Communication

1. The Neural Pathway

The gut is innervated by the vagus nerve, whose afferents (the sensory fibers that carry information from the body’s internal organs to the brain) detect various mechanical and chemical stimuli, including bacterial by-products, gut hormones, and neurotransmitters. This nerve plays a substantial role in mood regulation, and therapeutic vagus nerve stimulation has shown benefits in treating refractory depression and chronic pain.

The gut microbiome can influence emotional and behavioural responses by acting on vagal afferents. In animal studies, supplementation with probiotics like Lactobacillus rhamnosus and Bifidobacterium longum has alleviated anxiety and depression-like behaviours.

The enteric nervous system (ENS), often called the “gut brain” or “second brain”, contains millions of neurons that communicate with the CNS through vagal and spinal routes. Studies in germ-free mice have revealed that the absence of gut microbiota causes significant abnormalities in ENS structure and neurochemistry during early postnatal development, which can be reversed through colonisation.

Remarkably, gut bacteria modulate the synthesis of serotonin, with bacterial species like Clostridium perfringens influencing the expression of tryptophan hydroxylase-1, the rate-limiting enzyme in serotonin synthesis. Germ-free mice show significantly reduced serotonin concentrations compared to conventionally raised mice.

2. The Neuroendocrine Pathway

The gut microbiome is essential for the development and function of the hypothalamic-pituitary-adrenal (HPA) axis, which represents the core of the stress response system. Germ-free mice exhibit exaggerated HPA axis responses and reduced sensitivity to negative feedback signals, changes that can be reversed by administration of Bifidobacterium infantis at an early stage.

The microbiome also influences the production of short-chain fatty acids (SCFAs)—particularly butyrate, propionate, and acetate—which are derived from the fermentation of dietary fibers. These SCFAs affect mitochondrial energy metabolism through various transcription factors and have been shown to combat oxidative stress by up-regulating antioxidant enzyme activity.

3. The Immune Pathway

The gut microbiome is crucial for the development and integrity of both the gut barrier and the blood-brain barrier (BBB). Alterations in the microbiome down-regulate tight junction expression, potentially exposing both organs to harmful substances and triggering neuroinflammation.

The microglia—specialised immune cells in the brain—require constant input from the gut microbiome to adequately fulfil their roles in neuronal maturation and immune surveillance. Mice with limited microbial complexity display genetic and morphological features of microglia similar to those observed in germ-free mice, alterations that can be reversed through recolonisation.

The Gut Microbiome in ADHD: What Does Research Reveal?

Over the past several years, researchers have begun investigating whether individuals with ADHD have distinct gut microbiome profiles compared to healthy controls. While this field is still emerging, several studies have identified intriguing differences.

Compositional Differences in ADHD

Aarts and colleagues were among the first to report microbial composition differences in young adult patients with ADHD. Within the phylum Actinobacteria, they found that the genus Bifidobacterium was significantly increased in the ADHD cohort. Interestingly, they also found that the relative abundance of Bifidobacterium correlated with increased levels of the enzyme cyclohexadienyl dehydratase (CDT), which is involved in synthesising phenylalanine, a dopamine precursor.

A study by Jiang and colleagues in treatment-naïve ADHD children revealed a significantly lower concentration of the genus Faecalibacterium in the ADHD group, with the abundance of this genus negatively associated with parental reports of ADHD symptoms. This finding is particularly interesting because Faecalibacterium species are known for their anti-inflammatory properties.

Szopinska-Tokov and colleagues found a significant increase of the genus Ruminococcaceae in adolescents and young adults with ADHD, which was associated with inattention symptoms. On analysis, they discovered that this genus shared sequences with microbial species capable of consuming GABA, a neurotransmitter involved in ADHD pathophysiology.

In a German population, Prehn-Kristensen and colleagues observed that alpha diversity (species richness within samples) was significantly reduced in adolescents with ADHD and negatively correlated with hyperactivity levels. They also found higher abundance of the family Bacteroidaceae in ADHD samples. Interestingly, this reduction in alpha diversity was also observed in mothers of ADHD patients, suggesting potential maternal transmission of microbial features.

Using shotgun metagenomics sequencing in a Chinese pediatric population, Wan and colleagues found that Faecalibacterium was significantly decreased in ADHD patients, while Odoribacter and Enterococcus were significantly higher. Their analysis also revealed alterations in genes encoding enzymes involved in dopaminergic synaptic pathways.

Many of these are included within our Ultimate Gut Health test.

Linking Microbiome Changes to ADHD Symptoms

Several mechanisms may explain how these microbial differences contribute to ADHD symptoms:

Neurotransmitter Metabolism: Bacterial species can produce and respond to hormones and neurotransmitters. Lactobacillus species produce acetylcholine and GABA, Bifidobacterium species produce GABA, Escherichia produces norepinephrine, serotonin, and dopamine, while Streptococcus and Enterococcus produce serotonin. Alterations in these bacterial populations could directly impact neurotransmitter availability.

Inflammation and Oxidative Stress: Faecalibacterium species exert anti-inflammatory effects, and abnormal levels may lead to higher expression of inflammatory factors that could contribute to ADHD pathogenesis. The inflammatory state can exacerbate the oxidative stress and mitochondrial dysfunction already present in ADHD.

Short-Chain Fatty Acid Production: Changes in SCFA-producing bacteria could affect energy metabolism, BBB integrity, and neuroinflammation. Bacteroides and Clostridiae species are particularly active in SCFA production, and alterations in these populations may have downstream effects on brain function.

Methodological Considerations

It’s important to note that while these findings are promising, current research exhibits substantial heterogeneity due to differences in geographic location, dietary characteristics, control group selection, medication status, sequencing methods, and bioinformatics approaches. More standardised research protocols are needed to confidently identify specific microbial signatures associated with ADHD.

The Role of Omega-3 Fatty Acids and the Gut Microbiome

An intriguing connection exists between the gut microbiome, omega-3 polyunsaturated fatty acids (PUFAs), and ADHD. Omega-3 PUFAs, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), play crucial roles in membrane fluidity, neurotransmission, receptor function, and levels of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF)—a neuroprotective factor important for dopaminergic neurons.

Individuals with ADHD typically show significantly decreased total omega-3 PUFAs and a higher omega-6:omega-3 ratio compared to controls. In animal models of ADHD, a diet enriched in omega-3 PUFAs led to increased striatal turnover of dopamine and serotonin, improved attention, and decreased impulsivity.

The relationship between omega-3 PUFAs and the gut microbiome appears to be bidirectional:

Research in mice has shown that 8-week dietary supplementation with different strains of Bifidobacterium breve resulted in different fatty acid profiles in host tissues, with some strains leading to significantly higher concentrations of DHA in the brain.

Conversely, omega-3 supplementation influences gut microbial composition. Mice receiving an omega-3 enriched diet displayed improved cognition and social behavior, along with a significant increase in Lactobacillus and Bifidobacterium during adulthood.

In a human trial, 8-week supplementation with omega-3 PUFAs in healthy volunteers led to an increase in butyrate-producing genera including Bifidobacterium, Roseburia, and Lactobacillus.

This bidirectional relationship suggests that interventions targeting either omega-3 status or the gut microbiome might have synergistic effects on ADHD symptoms.

Recommended Product: Life and Soul

Sleep, Circadian Rhythms, and the Gut Microbiome in ADHD

Sleep disorders represent one of the most frequent co-morbidities in children with ADHD, present in up to 70% of patients. The most consistent finding is a delayed circadian phase (evening preference), with significantly delayed evening increases in endogenous melatonin secretion.

The gut microbiome exhibits its own circadian rhythms that depend on the central clock. Animal studies have shown that the diversity and abundance of certain bacterial species, such as Bacteroidetes and Clostridia, oscillate during the 24-hour light-dark cycle, with bacterial load higher during active phases and lower during rest phases.

Melatonin appears to impact the richness and diversity of the intestinal microbiota and the Firmicutes:Bacteroidetes ratio in mice. In sleep-deprived mice with lower plasma melatonin concentrations, researchers observed significantly decreased microbial diversity and richness, along with increased Firmicutes:Bacteroidetes ratio. Melatonin administration restored these parameters to normal levels and neutralised disruptions in pro-inflammatory/anti-inflammatory cytokine balance and redox status.

In children with autism spectrum disorder (a condition with substantial genetic overlap with ADHD), those with sleep disorders showed reduced abundance of butyrate-producing bacteria Faecalibacterium and Agathobacter, with these abundances negatively correlated with sleep problem scores. Concentrations of 3-hydroxybutyric acid (a butyrate-derived compound) and melatonin were significantly lower in the sleep disorder group, and these metabolites were positively correlated with beneficial bacterial abundances.

While direct research on the circadian-microbiome connection in ADHD populations is limited, these findings suggest that the sleep problems commonly experienced by individuals with ADHD may both influence and be influenced by gut microbiome composition.

Psychobiotics: Therapeutic Potential for ADHD

Given the documented involvement of the microbiome-gut-brain axis in ADHD pathophysiology, could modulating the gut microbiome offer therapeutic benefits? This is where psychobiotics come into play.

Psychobiotics are defined as probiotic bacteria-derived molecules that exert psychological potential to support mental health by targeting microbial interventions. These next-generation probiotics differ from typical probiotics in their ability to affect the gut-brain axis by modulating microbial composition, immune activation, vagal nerve signalling, and production of neuroactive metabolites.

Mechanisms of Psychobiotic Action in ADHD

Psychobiotics may benefit ADHD through several mechanisms:

1. Restoring Microbial Balance: By shifting gut dysbiosis toward eubiosis, psychobiotics can increase beneficial bacteria like Lactobacillus and Bifidobacterium species, which have been found at lower levels in some ADHD populations.

2. Anti-inflammatory Effects: Psychobiotics reduce gut inflammation through various mechanisms, including reducing inflammatory cytokines (TNF-α, IL-1β, IL-6) and increasing anti-inflammatory cytokines (IL-4, IL-10). Studies have shown that probiotic supplementation in children with ASD significantly decreased TNF-α levels, which were strongly correlated with gastrointestinal symptoms.

3. Neurotransmitter Modulation: Psychobiotics modulate CNS-related behaviours through the vagal nerve pathway and influence the production of various metabolites, including short-chain fatty acids, enteroendocrine hormones, cytokines, and neurotransmitters like GABA, serotonin, and dopamine.

4. Support for Dopaminergic Function: Bacillus species, known for their ability to produce dopamine and noradrenaline directly in the gastrointestinal tract, may support the dopaminergic system that is dysregulated in ADHD.

5. GABA System Enhancement: Lactobacillus and Bifidobacterium species produce GABA, a neurotransmitter known to decrease in patients with ADHD. Studies have shown that Lactobacillus rhamnosus regulates emotional behaviour and central GABA receptor expression via the vagus nerve.

Clinical Evidence for Psychobiotics in ADHD

Several clinical trials have explored the use of probiotics and synbiotics in ADHD populations:

Early-Life Intervention: In a landmark Finnish study, mothers received Lactobacillus rhamnosus GG supplementation starting 4 weeks before delivery and continuing for 6 months postpartum. At 13-year follow-up, none of the children in the probiotic group were diagnosed with ADHD or autism spectrum disorder, compared to 17.1% in the placebo group. Children who later developed neuropsychiatric disorders had significantly lower Bifidobacterium content at 6 months of age.

Direct ADHD Treatment: A pilot randomised controlled trial in children and adolescents with ADHD who received 3-month supplementation with Lactobacillus rhamnosus GG found significant improvement in quality of life scores and decreased levels of pro-inflammatory cytokines IL-12 p70 and TNF-α in the probiotic group.

Synbiotic Intervention: A study using Synbiotic 2000 (containing three lactic acid bacteria plus fermentable fibers) in children and adolescents with ADHD showed a tendency toward reduction of autistic symptoms, particularly in those with elevated inflammatory markers who were not taking ADHD medication.

Micronutrient-Microbiome Connection: A trial investigating micronutrient supplementation in male children with ADHD found that treatment was associated with a 25% reduction in the genus Bifidobacterium, and lower concentrations of Actinobacteria correlated with lower ADHD symptom scores and better overall functioning.

Recommended Product: Advanced Daily Biotic (Lactobacillus rhamnosus GG).

Fecal Microbiota Transplantation

Beyond probiotics, fecal microbiota transplantation (FMT) represents a more comprehensive approach to microbiome modulation. FMT involves transferring the entire fecal microbiome from a healthy donor to a recipient, with the goal of reestablishing a normally functioning microbial community.

In studies of autism spectrum disorder, microbiota transfer therapy has shown promise in altering gut microbiome composition at both phylum and genus levels, with therapeutic effects on both gastrointestinal and behavioural symptoms. Important changes included significant increases in bacterial diversity and relative abundance of Bifidobacteria and Prevotella, with the microbiome changes persisting for two years after treatment.

A case report of FMT in a patient with both C. difficile infection and ADHD suggested that gut microbiome modulation, particularly involving species and pathways related to SCFA, tryptophan, and GABA metabolism, may merit exploration as a potential therapeutic strategy for ADHD. Among bacteria engrafted through FMT, Faecalibacterium prausnitzii may reduce neuroinflammation and alleviate ADHD symptoms through anti-inflammatory effects and SCFA production.

While FMT shows promise, more research specific to ADHD populations is needed before this approach can be recommended as a treatment option.

Practical Implications For ADHD And Gut Health

Dietary Considerations

Given the role of the microbiome in ADHD, dietary interventions that support gut health may offer complementary benefits:

Fiber-Rich Foods: Consuming adequate dietary fiber feeds beneficial bacteria that produce SCFAs. Choose foods like whole grains, legumes, fruits, and vegetables should be emphasised.

Omega-3 Rich Foods: Given the bidirectional relationship between omega-3 PUFAs and the microbiome, including fatty fish, walnuts, flaxseeds, and chia seeds may support both brain health and microbial balance.

Fermented Foods: Traditional fermented foods like yogurt, kefir, sauerkraut, kimchi, and kombucha contain live beneficial bacteria that may support gut health.

Limiting Processed Foods: Highly processed foods, artificial additives, and excessive sugar can negatively impact microbial diversity and promote inflammatory species.

The Role of Probiotics

While research is promising, it’s important to approach probiotic supplementation thoughtfully:

• Strain Specificity: Different bacterial strains have different effects. Lactobacillus and Bifidobacterium species have shown the most consistent benefits in neuropsychiatric research.
• Early Intervention: The gut microbiome has critical windows of development, particularly during the first three years of life, when interventions may have the most significant long-term impact.
• Individual Variability: Responses to probiotics can vary based on existing microbiome composition, genetics, diet, and other factors.
• Quality Matters: Choose probiotics from reputable manufacturers with documented colony-forming units (CFUs) and strains that have been researched.

Future Research Needs

Considerable work remains to standardise research on psychobiotics in ADHD, including identification of the most effective doses and strain combinations, determination of minimum intervention periods to observe clinically meaningful results, and establishment of protocols for microbiome analysis.

Future studies should:

• Use larger, more diverse sample populations with careful stratification for confounding factors.
• Employ standardised diagnostic criteria and psychometric assessments.
• Utilise high-resolution sequencing techniques beyond 16S rDNA.
• Include longitudinal follow-up to assess durability of effects.
• Investigate mechanisms through which specific strains influence ADHD symptoms.
• Explore personalised approaches based on individual microbiome profiles.
• Examine the interaction between gut health interventions and conventional ADHD treatments.

Conclusion

The emerging research on the gut-brain axis in ADHD represents a paradigm shift in how we understand this complex neurodevelopmental disorder. Rather than viewing ADHD solely as a brain-based condition, we now recognise that the gut microbiome plays a significant role in the neuroinflammation, oxidative stress, neurotransmitter dysregulation, and metabolic dysfunction that characterise the disorder.

While we cannot yet definitively state that ADHD is caused by gut dysbiosis, the evidence strongly suggests that the microbiome is an important player in the condition’s pathophysiology. The bidirectional nature of the gut-brain axis means that ADHD-related stress, dietary choices, medication use, and sleep disruption can affect the microbiome, which in turn may exacerbate symptoms—creating potential vicious cycles.

The therapeutic potential of psychobiotics and microbiome-targeted interventions is promising but requires further investigation. Early intervention studies suggest that supporting healthy gut microbiome development from infancy may reduce the risk of later neurodevelopmental problems. For those already living with ADHD, probiotic supplementation, dietary modifications that support gut health, and attention to sleep and circadian rhythms may offer complementary benefits to conventional treatments.

As research in this field continues to evolve, we may see gut health assessments become part of routine ADHD evaluation, and microbiome-targeted therapies may emerge as valuable tools in the comprehensive management of ADHD. For now, supporting gut health through diet, lifestyle, and potentially probiotic supplementation represents a low-risk, potentially beneficial approach that aligns with overall health optimisation.

This research therefore reminds us that the brain does not function in isolation—it is intimately connected to every system in the body, including the trillions of microorganisms that call our gut home. By nurturing these microscopic partners, we may unlock new pathways to better brain health and improved outcomes for those living with ADHD.

---

References

1. Kwak et al., (2023). Psychobiotics and fecal microbial transplantation for autism and attention-deficit/hyperactivity disorder: microbiome modulation and therapeutic mechanisms (click here)
2. Góralczyk-Bińkowska et al., (2022). The Microbiota–Gut–Brain Axis in Psychiatric Disorders. International Journal of Molecular Sciences, 23(19), 11245. (click here)
3. Checa-Ros et al., (2021). Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients, 13(1), 249. (click here)
4. Aarts et al. (2017). Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS ONE, 12(9), e0183509.  (click here)
5. Jiang et al. (2018). Gut microbiota profiles in treatment-naive children with attention deficit hyperactivity disorder. Behavioural Brain Research, 347, 408-413 (click here).
6. Pärtty et al., (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric Research, 77(6), 823-828 (click here).
7. Cryan et al. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. (click here)
8. Bercik et al. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141(2), 599-609. (click here)
9. Robertson et al. (2017). Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain, Behavior, and Immunity, 59, 21-37. (click here)
10. Hua et al. (2020). The Gut Microbiota and Associated Metabolites Are Altered in Sleep Disorder of Children With Autism Spectrum Disorders (click here)